Search Results
FDA Drug Info Rounds, July 2012: Patents and Exclusivity
FDA Drug Info Rounds, July 2012: Accelerated Approval Program
Understanding Patent and Exclusivity
FDA Drug Info Rounds, October 2012: Distribution of Medication Guides
An Overview of FDA's Patent Listing Process
FDA Drug Info Rounds, November 2012: Drug Safety Communications
Orange Book Exclusivity: Part I - NCE and 3-Year
Orange Book Exclusivity: Part III - 180-Day and Competitive Generic Therapy Exclusivities
Orange Book Exclusivity: An Introduction and Overview
Orange Book Exclusivity: Part II - Pediatric, Orphan, and GAIN
JumpStarting Drug Review
Determining Whether to Submit an ANDA or a 505(b)(2) Application- FDA Generic Drug Forum 2018
